Clinical Research Directory
Browse clinical research sites, groups, and studies.
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Sponsor: Jason Sperry
Summary
The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
1050
Start Date
2024-06-30
Completion Date
2028-03
Last Updated
2026-03-16
Healthy Volunteers
No
Conditions
Interventions
Calcium Gluconate
1 gram calcium gluconate provided via intravenous or intraosseous access over approximately 2-5 minutes
Vasopressin
4 unit vasopressin bolus followed by vasopressin infusion at 0.04 U/min for eight hours
saline placebo
saline placebo volume matched to prehospital or in hospital phase
Locations (13)
University of Arizona
Tucson, Arizona, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco
San Francisco, California, United States
Denver Health Medical Center
Denver, Colorado, United States
University of Miami
Miami, Florida, United States
Hennepin County Medical Center
Minneapolis, Minnesota, United States
University of Missouri Health Care
Columbia, Missouri, United States
University of New Mexico
Albuquerque, New Mexico, United States
Mount Carmel East Hospital
Columbus, Ohio, United States
Allegheny Health Network
Pittsburgh, Pennsylvania, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Texas Tech University Health Sciences Center
Lubbock, Texas, United States
University of Washington Harborview Medical Center
Seattle, Washington, United States